To evaluate the pituitary-adrenal axis function by means of the adrenocorticotropic hormone (ACTH) stimulation test following a single intravitreal injection of triamcinolone acetonide (IVTA). Prospective comparative clinical interventional study. Twenty-eight patients (28 eyes) received a single IVTA (4 mg in 0.1 ml) for macular edema. The basal cortisol level and the response to 1 μg adrenocorticotropic hormone stimulation were determined on the morning before IVTA injection and at 1 day and 1, 2, and 4 weeks after IVTA injection. Results were compared with those obtained from a control group of 50 healthy subjects. All patients in the study had normal basal cortisol and normal response to ACTH challenge before receiving IVTA. 1 day following IVTA, basal cortisol was suppressed in one patient in the study group. Fasting serum cortisol levels at 1, 2, and 4 weeks after IVTA injection were normal in all patients in the study group. 1 day following IVTA, the peak response to ACTH at 30 min was blunted in four patients (14.3 % of the study group, p = 0.05) and the cortisol response at 60 min was suppressed (p = 0.009). 1 week following IVTA, the response to ACTH challenge was blunted in only one patient. A single IVTA injection may be associated with impaired hypothalamic-pituitary-adrenal function in some patients during the first 24 h following IVTA.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s10792-012-9659-5 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Comparative Analytical Study of Intravitreal Triamcinolone Acetonide Versus Bevacizumab in Managing Diabetic Macular Edema: Insights From a Tertiary Eye Care Facility in India.
Cureus
November 2024
Ophthalmology, Institute of Ophthalmology, Joseph Eye Hospital, Tiruchirappalli, IND.
Aim: This study aims to compare the effects of intravitreal triamcinolone acetonide (IVTA) and bevacizumab (IVB) in diabetic macular edema (DME) management.
Methodology: A prospective interventional study was conducted at a tertiary eye care hospital in Tamil Nadu, India. The study received approval from the institutional ethics committee, and informed consent was obtained from all participants.
Multimodal imaging to distinguish microvascular and morphological changes in retinal vein occlusion after intravitreal ranibizumab with or without triamcinolone acetonide injection.
BMC Ophthalmol
August 2024
Department of Ophthalmology, The Second Xiangya Hospital, Central South University, 139 Renmin Middle Road, Changsha, 410011, China.
Article Synopsis
- The study aimed to explore changes in the retina of patients with retinal vein occlusion (RVO) after treatment with intravitreal ranibizumab (IVR), with or without triamcinolone acetonide (IVTA).
- It included 50 patients and used multiple imaging techniques to assess visual acuity and retinal structure before and after treatment.
- Results showed significant improvements in vision and retinal structure with both treatment options, but using IVR with IVTA led to better visual outcomes and increased intraocular pressure compared to IVR alone.
Biomechanic, proteomic and miRNA transcriptional changes in the trabecular meshwork of primates injected with intravitreal triamcinolone.
Vision Res
September 2024
Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California-Davis, Davis, CA, 95616, USA; Department of Ophthalmology & Vision Science, School of Medicine, University of California-Davis, Davis, CA, 95817, USA; California National Primate Research Center, University of California-Davis, Davis, CA, 95616, USA. Electronic address:
Although biomechanical changes of the trabecular meshwork (TM) are important to the pathogenesis of glucocorticoids-induced ocular hypertension (GC-OHT), there is a knowledge gap in the underlying molecular mechanisms of the development of it. In this study, we performed intravitreal triamcinolone injection (IVTA) in one eye of 3 rhesus macaques. Following IVTA, we assessed TM stiffness using atomic force microscopy and investigated changes in proteomic and miRNA expression profiles.
View Article and Find Full Text PDFEvaluation of clinical outcomes of raised intraocular pressure following intravitreal triamcinolone acetonide injection.
Rom J Ophthalmol
April 2024
Department of Vitreoretina services, MM Joshi Eye Institute, Karnataka, India.
To assess the incidence, risk factors, and treatment outcomes in intravitreal triamcinolone acetonide injection (IVTA) induced intraocular pressure rise and to compare IOP rise in 1-mg and 2-mg IVTA. Prospective observational study conducted in all eyes receiving IVTA. Any pre-existing glaucoma and patients who received IVTA or dexamethasone implant in the last 6 months were excluded.
View Article and Find Full Text PDFPhacoemulsification in patients with diabetic macular edema - A real-world data of 75 eyes.
Oman J Ophthalmol
February 2024
Department of Shri Bhagwan Mahavir Vitreoretinal Services, Sankara Nethralaya, Chennai, Tamil Nadu, India.
Article Synopsis
- The study aimed to assess the effects of phacoemulsification combined with an intravitreal triamcinolone acetonide injection on patients with cataracts and diabetic macular edema across varying levels of diabetic retinopathy.
- It involved 70 patients, with results showing significant improvements in best-corrected visual acuity (BCVA) and reductions in central macular thickness (CMT) at both 3 weeks and 3 months post-surgery.
- Overall, two-thirds of the patients experienced improved vision, and nearly half showed reduced macular thickness shortly after the surgery.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!